11 hours ago
SMS Pharmaceuticals share jump 6% after its Hyderabad facility clears USFDA inspection with zero observations
By Aman Shukla Published on June 26, 2025, 09:24 IST
Shares of SMS Pharmaceuticals surged 6% in early trade after the company announced the successful completion of a USFDA inspection at its Central Laboratory Analytical Services in Gagillapur, Hyderabad. As of 9:23 AM, the shares were trading 5.77% higher at Rs 252.90.
The inspection, conducted between June 23 and June 25, 2025, concluded with zero Form 483 observations — a clear indicator of full compliance with USFDA norms. This is the second successful USFDA audit at the lab, underlining the company's robust quality assurance systems and regulatory preparedness.
The Central Lab operates as an independent analytical testing facility, serving as a key quality control hub for the company. The clean report from the USFDA reinforces SMS Pharma's strong adherence to Current Good Manufacturing Practices (CGMP) and Good Laboratory Practices (GLP) across its operations.
This development boosts investor confidence, as regulatory compliance plays a crucial role in pharmaceutical exports to the US — one of SMS Pharma's key markets. It also strengthens the company's reputation as a trusted global pharmaceutical player, with a sharp focus on quality, safety, and transparency.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
